N-(7-OXADECYL)-2,4-DI-O-BUTYRYL-1,5-DIDEOXY-1,5-IMINO-D-GLUCITOL
Compound with spectra: 1 NMR
| SpectraBase Compound ID | 2w2wOGkQEfP |
|---|---|
| InChI | InChI=1S/C23H43NO7/c1-4-11-20(26)30-19-16-24(13-9-7-8-10-15-29-14-6-3)18(17-25)23(22(19)28)31-21(27)12-5-2/h18-19,22-23,25,28H,4-17H2,1-3H3/t18-,19+,22-,23-/m0/s1 |
| InChIKey | UPAVAUNVSQDWOU-YDLSIGKMSA-N |
| Mol Weight | 445.6 g/mol |
| Molecular Formula | C23H43NO7 |
| Exact Mass | 445.303953 g/mol |
| Enantiomer InChIKey | UPAVAUNVSQDWOU-IYRWYFENSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CD3OD |
1-O-(PHENYLACETYL)-(1S,6S,7R,8R,8AR)-1,6,7,8-TETRAHYDROXYOCTAHYDROINDOLIZINE;1-O-(PHENYLACETYL)-CASTANOSPERMINE
2,6-DIDEOXY-2,6-IMINO-3,4-O-ISOPROPYLIDENE-2-N-NONYL-D-ALLONONITRILE
N-Benzyl-3,6-dibenzoyl-4,5-O-(isopropylidene)azepane
2-N-BUTYL-2,6-DIDEOXY-2,6-IMINO-3,4-O-ISOPROPYLIDENE-D-ALLONONITRILE
2-N-BUTYL-2,6-DIDEOXY-2,6-IMINO-3,4-O-ISOPROPYLIDENE-D-ALTRONONITRILE
(2S,3R,4S,5R)-2-(AMINOMETHYL)-1-BENZYL-3-HYDROXY-4,5-(ISOPROPYLIDENEDIOXY)-PIPERIDINE
1'-[(1,4-DIDEOXY-1,4-IMINO-D-ARABINITOL)-4-N-AMMONIUM]-2',4'-O-BENZYLIDENE-1'-DEOXY-L-ERYTHRITOL-3'-SULFATE
1'-[(1,4-DIDEOXY-1,4-IMINO-D-XYLITOL)-4-N-AMMONIUM]-2',4'-O-BENZYLIDENE-1'-DEOXY-L-ERYTHRITOL-3'-SULFATE
(3aR,9R,9aR,9bS)-9-(Hydroxy)-1,2-(isopropylidenedioxy)indolizine
(1R),2(S),8(S),8a(R)-1,2-O-Isopropylideneoctahydro-1,2,8-indolizidinetriol
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of oxygen-substituted N-alkyl 1-deoxynojirimycin derivatives: Aza sugar α-glucosidase inhibitors showing antiviral (HIV-1) and immunosuppressive activity | Recueil des Travaux Chimiques des Pays-Bas | 1994 |
This compound is available in the following databases:
KnowItAll NMR Spectral Library
Author: Wiley
The KnowItAll NMR Spectral Library offers a comprehensive collection of NMR reference spectra, including NMR, CNMR, and XNMR, and covers a wide range of compounds including organics, polymers, monomers, metabolites, and more. Learn more.